We Translate Science Into Treatment

Our co-workers build our company. We believe that our workplace should not only be full of expertise but also of warmth, transparency and flexibility. A place that is open for fast adaptation to new, innovative techniques. Committed to our work, we aim for high-quality deliverables that will meet your expectations. All to facilitate the translation of science into treatment.

Preclinical phase

We can guide you already at the early stage of drug development and answer scientific and regulatory questions regarding both the preclinical program and the clinical development plan.


Our FIH research unit has 12 hospital beds and is conveniently located adjacent to the ICU, PET-centre and MRI-facilities at Uppsala University Hospital. Safety always comes first.

Phase I-II

Oscar has 24 beds and is located in conjunction with CTC’s head office, next to the hospital. At this research unit we offer bioavailability and bioequivalence studies.